The ChEMBL database: A taster for medicinal chemists

Future Medicinal Chemistry

Volumn 6, Issue 4, 2014, Pages 361-364

  Papadatos, George ^a   Overington, John P ^b  

^a EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Italy)

Author keywords

chemogenomics; databases; open data; patents

Indexed keywords

ALGORITHM; CHEMBL DATABASE; COMPUTER LANGUAGE; COMPUTER PROGRAM; DATA BASE; DATA MINING; DATA PROCESSING; PRIORITY JOURNAL; REVIEW;

CHEMISTRY, PHARMACEUTICAL; DATABASES, FACTUAL; PROTEIN KINASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84897001699     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.14.8     Document Type: Review

References (42)

1. Gaulton A, Bellis LJ, Bento AP et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40(database issue), D1100-D1107 (2011).
2. Bento AP, Gaulton A, Hersey A et al. The ChEMBL bioactivity database: an update. Nucleic Acids Res. doi:10.1093/nar/gkt1031 (2013).
3. Wang Y, Suzek T, Zhang J et al. PubChem BioAssay: 2014 update. Nucleic Acids Res. 42(1), D1075-D1082 (2013).
4. Gao Y, Davies SP, Augustin M et al. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. Biochem. J. 451(2), 313-328 (2013).
5. Dranchak P, Macarthur R, Guha R et al. Profile of the GSK published protein kinase inhibitor set across ATP-dependent and-independent luciferases: implications for reporter-gene assays. PLoS ONE 8(3), e57888 (2013).
6. DrugMatrix. https://ntp.niehs.nih.gov/drugmatrix/index.html
7. The ChEMBL database. www.ebi.ac.uk/chembl
8. Accelrys Pipeline Pilot. http://accelrys.com/products/pipeline-pilot
9. KNIME. www.knime.org/knime
10. ChEMBL SPARQL endpoint. www.ebi.ac.uk/rdf/services/chembl/sparql
11. Williams AJ, Harland L, Groth P et al. Open PHACTS: semantic interoperability for drug discovery. Drug Discov. Today 17(21-22), 1188-1198 (2012).
12. Ochoa R, Davies M, Papadatos G, Atkinson F, Overington JP. myChEMBL: a virtual machine implementation of open data and cheminformatics tools. Bioinformatics 30(2), 298-300 (2013).
13. The RDKit toolkit. www.rdkit.org
14. Hersey A, Senger S, Overington JP. Open data for drug discovery: learning from the biological community.Future Med. Chem. 4(15), 1865-1867 (2012).
15. Tiikkainen P, Bellis L, Light Y, Franke L. Estimating error rates in bioactivity databases. J. Chem. Inf. Model. 53(10), 2499-2505 (2013).
16. Hopkins AL, Groom CR, Alex A: Ligand efficiency: a useful metric for lead selection. Drug Discov. Today 9(10), 430-431 (2004).
17. Abad-Zapatero C, Metz JT. Ligand efficiency indices as guideposts for drug discovery. Drug Discov. Today 10(7), 464-469 (2005).
18. Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-making in medicinal chemistry.Nat. Rev. Drug Discov. 6(11), 881-890 (2007).
19. Congreve M, Carr R, Murray C, Jhoti H. A 'rule of three' for fragment-based lead discovery? Drug Discov. Today 8(19), 876-877 (2003).
20. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3-25 (1997).
21. Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL. Quantifying the chemical beauty of drugs. Nat. Chem. 4(2), 90-98 (2012).
22. ChEMBL NTD. www.ebi.ac.uk/chemblntd
23. Malaria-Data. www.ebi.ac.uk/chembl/malaria
24. Open Source Malaria. http://opensourcemalaria.org
25. Spangenberg T, Burrows JN, Kowalczyk P, Mcdonald S, Wells TNC, Willis P. The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS ONE 8(6), e62906 (2013).
26. Wang L, Ma C, Wipf P, Liu H, Su W, Xie X-Q. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database. AAPS J. 15(2), 395-406 (2013).
27. Wirth M, Zoete V, Michielin O, Sauer WHB. SwissBioisostere: a database of molecular replacements for ligand design. Nucleic Acids Res. 41(D1), D1137-D1143 (2013).
28. Halling-Brown MD, Bulusu KC, Patel M, Tym JE, Al-Lazikani B. canSAR: an integrated cancer public translational research and drug discovery resource. Nucleic Acids Res. 40(database issue), D947-D956 (2011).
29. Lounkine E, Keiser MJ, Whitebread S et al. Large-scale prediction and testing of drug activity on side-effect targets. Nature 486(7403), 361-367 (2012).
30. Martínez-Jiménez F, Papadatos G, Yang L et al. Target prediction for an open access set of compounds active against Mycobacterium tuberculosis. PLoS Comput. Biol. 9(10), e1003253 (2013).
31. Besnard J, Ruda GF, Setola V et al. Automated design of ligands to polypharmacological profiles. Nature 492(7428), 215-220 (2012).
32. Fechner N, Papadatos G, Evans D et al. ChEMBLSpace -a graphical explorer of the chemogenomic space covered by the ChEMBL database.Bioinformatics doi:10.1093/bioinformatics/bts711 (2012).
33. Wassermann AM, Bajorath J. Large-scale exploration of bioisosteric replacements on the basis of matched molecular pairs. Future Med. Chem. 3(4), 425-436 (2011).
34. Hu Y, Bajorath J. Extending the activity cliff concept: structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database. J. Chem. Inf. Model. 52(7), 1806-1811 (2012).
35. Papadatos G, Brown N. In silico applications of bioisosterism in contemporary medicinal chemistry practice. Wiley Interdisciplinary Reviews: Computational Molecular Science 3(4), 339-354 (2013).
36. Kramer C, Kalliokoski T, Gedeck P, Vulpetti A. The experimental uncertainty of heterogeneous public Ki data. J. Med. Chem. 55(11), 5165-5173 (2012).
37. Kalliokoski T, Kramer C, Vulpetti A, Gedeck P. Comparability of mixed IC50 data -a statistical analysis. PLoS ONE 8(4), e61007 (2013).
38. Riniker S, Landrum G. Open-source platform to benchmark fingerprints for ligand-based virtual screening. J. Cheminf. 5(1), 26 (2013).
39. Bregonje M. Patents: A Unique Source for Scientific Technical Information in Chemistry Related Industry? World Patent Information 27, 309-315 (2005).
40. SureChem. https://surechem.com
41. SureChEMBL. www.surechembl.org
42. Chambers J, Davies M, Gaulton A et al. UniChem: a unified chemical structure cross-referencing and identifier tracking system. J. Cheminf. 5(1), 3 (2013).